Geron Corp (GERN)
3.34
0.00 (0.00%)
USD |
NASDAQ |
Dec 24, 16:00
Geron Free Cash Flow: -216.50M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Emergent BioSolutions Inc | 138.10M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -58.94M |
| Cash from Investing (Quarterly) | -0.554M |
| Cash from Financing (Quarterly) | 3.578M |
| Free Cash Flow Per Share (Quarterly) | -0.089 |
| Free Cash Flow to Equity (Quarterly) | -59.34M |
| Free Cash Flow Yield | -10.31% |